• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星对耐抗分枝杆菌药物的分枝杆菌临床分离株的体外活性。

In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.

作者信息

Marinis E, Legakis N J

出版信息

J Antimicrob Chemother. 1985 Oct;16(4):527-30. doi: 10.1093/jac/16.4.527.

DOI:10.1093/jac/16.4.527
PMID:2933382
Abstract

The activity of ciprofloxacin against 42 clinical isolates of mycobacteria was studied in vitro by the 1% standard proportion method on Lowenstein-Jensen medium. Ciprofloxacin was found active against all strains of Mycobacterium tuberculosis sensitive to streptomycin, isoniazid, ethambutol and rifampicin. The MIC of ciprofloxacin was 3.2 mg/l. This concentration of ciprofloxacin was sufficient to inhibit almost all strains showing intermediate sensitivity or resistance to one or more of the above agents. The same phenomenon was also observed with the atypical isolates.

摘要

采用1%标准比例法在罗-琴培养基上,对环丙沙星针对42株临床分枝杆菌分离株的活性进行了体外研究。发现环丙沙星对所有对链霉素、异烟肼、乙胺丁醇和利福平敏感的结核分枝杆菌菌株均有活性。环丙沙星的最低抑菌浓度为3.2mg/L。该浓度的环丙沙星足以抑制几乎所有对上述一种或多种药物表现出中度敏感性或耐药性的菌株。在非典型分离株中也观察到了同样的现象。

相似文献

1
In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.环丙沙星对耐抗分枝杆菌药物的分枝杆菌临床分离株的体外活性。
J Antimicrob Chemother. 1985 Oct;16(4):527-30. doi: 10.1093/jac/16.4.527.
2
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.环丙沙星及其他4-喹诺酮类药物对结核分枝杆菌和胞内分枝杆菌的体外活性比较
Antimicrob Agents Chemother. 1986 Mar;29(3):386-8. doi: 10.1128/AAC.29.3.386.
3
Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.环丙沙星对分枝杆菌的体外活性:BACTEC法与大管肉汤稀释法的比较
J Antimicrob Chemother. 1987 May;19(5):617-22. doi: 10.1093/jac/19.5.617.
4
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.四种氟喹诺酮类药物对86株分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.
5
Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.氧氟沙星、环丙沙星和格帕沙星的抗分枝杆菌活性比较。
J Antimicrob Chemother. 1999 Nov;44(5):647-52. doi: 10.1093/jac/44.5.647.
6
[In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].环丙沙星和氧氟沙星对结核分枝杆菌、鸟分枝杆菌、非洲分枝杆菌、堪萨斯分枝杆菌及卡介苗菌株的体外活性
Immun Infekt. 1986 Nov;14(6):203-7.
7
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.五种氟喹诺酮类药物对分枝杆菌的体外活性比较
J Antimicrob Chemother. 1987 May;19(5):605-9. doi: 10.1093/jac/19.5.605.
8
Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime.乙胺丁醇与β-内酰胺类药物头孢吡肟之间的协同抗分枝杆菌活性。
Diagn Microbiol Infect Dis. 1997 Jul;28(3):119-22. doi: 10.1016/s0732-8893(97)00012-6.
9
In-vitro activity of quinolones and macrolides against mycobacteria.喹诺酮类和大环内酯类药物对分枝杆菌的体外活性。
J Antimicrob Chemother. 1994 Sep;34(3):343-51. doi: 10.1093/jac/34.3.343.
10
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.

引用本文的文献

1
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
2
Mycobacteria and the new quinolones.分枝杆菌与新型喹诺酮类药物。
Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.